European digital healthcare provider Oviva closes €200 million Series…

Team S · 2026-01-30T14:08:09.000Z

Oviva, a Switzerland-based digital health leader providing reimbursed care for weight-related and chronic conditions, has successfully closed a €200 million (≈ $234 million) Series D funding round, making it one of the largest late-stage financings in the digital healthcare space in Europe. The company’s technology-powered platform combines personalised lifestyle, behavioural interventions and clinician-supported care often reimbursed through national systems to support patients in managing conditions such as obesity, hypertension and type 2 diabetes, while helping health systems improve outcomes and reduce long-term costs. Oviva’s model integrates continuous care pathways with scalable digital tools to deliver measurable results for patients and providers alike. This Series D was led by Kinnevik, which committed approximately €100 million, with strong participation from Planet First Partners, A.P. Moller Holding, Lunate, EGS Beteiligungen AG and Norrsken VC, while existing backer Sofina continued its support underscoring broad investor confidence in Oviva’s growth trajectory and strategic role in modernising chronic care delivery. The new capital will be used to expand reimbursed chronic care programmes, deepen AI-driven clinical support tools, and accelerate expansion across Europe’s healthcare markets, where demand for scalable, evidence-based digital solutions continues to grow.

Member Login Get Access

European digital healthcare provider Oviva closes €200 million Series… | Newnex